We are live on ! Find out more
WIA

Wealthstreet Investment Advisors Portfolio holdings

AUM $3.71M
1-Year Est. Return 13.1%
This Fund
S&P 500
This Quarter Est. Return
+12.06%
1 Year Est. Return
+13.1%
3 Year Est. Return
+75.79%
5 Year Est. Return
10 Year Est. Return
AUM
$989M
AUM Growth
+$93.9M
Cap. Flow
+$355K
Cap. Flow %
0.04%
Top 10 Hldgs %
27.14%
Holding
365
New
30
Increased
78
Reduced
122
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 20.44%
2 Healthcare 17.54%
3 Financials 9.27%
4 Industrials 8.89%
5 Consumer Staples 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VO icon
76
Vanguard Morningstar Mid-Cap ETF
VO
$110B
$2.94M 0.3%
56,808
NEE icon
77
NextEra Energy
NEE
$176B
$2.89M 0.29%
37,420
RSP icon
78
Invesco S&P 500 Equal Weight ETF
RSP
$100B
$2.84M 0.29%
22,250
-500
-2% -$59.5K
MDLZ icon
79
Mondelez International
MDLZ
$80.4B
$2.83M 0.29%
48,397
+230
+0.5% +$13.1K
SRPT icon
80
Sarepta Therapeutics
SRPT
$2.06B
$2.79M 0.28%
16,375
-1,500
-8% -$222K
TGT icon
81
Target
TGT
$74.5B
$2.73M 0.28%
15,486
+200
+1% +$33.4K
GE icon
82
GE Aerospace
GE
$368B
$2.69M 0.27%
49,872
+9,434
+23% +$423K
XBI icon
83
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$2.65M 0.27%
18,825
-144
-0.8% -$18.4K
VTI icon
84
Vanguard Morningstar Total Stock Market ETF
VTI
$685B
$2.64M 0.27%
13,561
+450
+3% +$82.3K
CVS icon
85
CVS Health
CVS
$121B
$2.62M 0.27%
38,424
-500
-1% -$32.5K
NKE icon
86
Nike
NKE
$57.2B
$2.61M 0.26%
18,456
-100
-0.5% -$13.2K
BRK.B icon
87
Berkshire Hathaway Class B
BRK.B
$1.08T
$2.58M 0.26%
11,121
+200
+2% +$44K
EEM icon
88
iShares MSCI Emerging Markets ETF
EEM
$31.2B
$2.55M 0.26%
49,393
+14,580
+42% +$701K
XLRN
89
DELISTED
Acceleron Pharma
XLRN
$2.55M 0.26%
19,950
VB icon
90
Vanguard Morningstar Small-Cap ETF
VB
$82.2B
$2.51M 0.25%
12,898
ISTB icon
91
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.09B
$2.48M 0.25%
47,935
-600
-1% -$30.9K
JPST icon
92
JPMorgan Ultra-Short Income ETF
JPST
$40.8B
$2.46M 0.25%
48,467
-16,050
-25% -$815K
GS icon
93
Goldman Sachs
GS
$303B
$2.41M 0.24%
9,125
-150
-2% -$33.4K
CCI icon
94
Crown Castle
CCI
$32.1B
$2.4M 0.24%
15,075
MCD icon
95
McDonald's
MCD
$189B
$2.38M 0.24%
11,112
+720
+7% +$157K
BMRN icon
96
BioMarin Pharmaceuticals
BMRN
$12.7B
$2.38M 0.24%
27,138
+2,720
+11% +$216K
SBAC icon
97
SBA Communications
SBAC
$19.7B
$2.33M 0.24%
8,265
SCHD icon
98
Schwab US Dividend Equity ETF
SCHD
$112B
$2.31M 0.23%
108,264
+59,505
+122% +$1.21M
EFA icon
99
iShares MSCI EAFE ETF
EFA
$80B
$2.31M 0.23%
31,700
+69
+0.2% +$4.72K
MO icon
100
Altria Group
MO
$115B
$2.31M 0.23%
56,339
-500
-0.9% -$20.1K

Similar funds

Wealthstreet Investment Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Wealthstreet Investment Advisors held 365 positions worth $989M, up 10% from $895M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Wealthstreet Investment Advisors's Q4 2020 filing shows 30 new, 78 increased, 122 reduced and 15 closed positions. Its largest new stake was Bristol-Myers Squibb: 284,659 shares worth $17.7M. The largest sale was Bristol-Myers Squibb Company Contingent Value Rights, an estimated $17.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Wealthstreet Investment Advisors's largest Q4 2020 buy was Bristol-Myers Squibb: 284,659 shares worth $17.7M.
  • Wealthstreet Investment Advisors added most to Alibaba in Q4 2020, an estimated $1.84M increase.
  • Wealthstreet Investment Advisors's biggest Q4 2020 reduction was iShares US Healthcare Providers ETF, cutting an estimated $2.82M.
  • Wealthstreet Investment Advisors fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020, selling an estimated $17.9M.
  • Wealthstreet Investment Advisors's ten largest holdings make up 27% of its $989M portfolio in Q4 2020.
  • Wealthstreet Investment Advisors opened 30 new positions and closed 15 in Q4 2020.
  • Wealthstreet Investment Advisors's portfolio value rose 10% quarter-over-quarter to $989M.

Based on Wealthstreet Investment Advisors's 13F filing for Q4 2020, filed 20 Jan 2021.